BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. [electronic resource]
Producer: 20180314Description: 55-57 p. digitalISSN:- 1464-410X
- Administration, Intravesical
- Australia
- BCG Vaccine -- administration & dosage
- Clinical Trials, Phase III as Topic
- Disease-Free Survival
- Female
- Humans
- Male
- Mitomycin -- administration & dosage
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Prognosis
- Randomized Controlled Trials as Topic
- Risk Assessment
- Survival Analysis
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Letter; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.